By Ben Dummett
Barclays has poached a senior investment banker from Deutsche Bank to bolster its coverage of European health care as deals such as Takeda Pharmaceutical Co.'s (TKPYY) $62 billion pact to acquire Shire highlight the opportunity for deal making in the sector.
Darren Campili is joining the U.K. bank as a vice-chairman focused on advising Europe's big pharmaceutical companies on mergers and acquisitions and fund raising, Barclays said Thursday.
Drug companies often rely on acquisitions over research and development as a quicker and less costly way of replenishing their drug pipelines.
Based in London, Mr. Campili will work closely with other senior Barclays health-care bankers globally including Axel-Sven Malkomes, another Barclays vice chairman in the health-care investment banking group, who is based in Frankfurt.
The addition brings to nine the number of senior investment bankers Barclays has hired so far this year in Europe, underscoring the bank's efforts to expand its investment-banking operations as part of a broader strategy to generate growth from its different divisions.
The Wall Street Journal reported earlier this week that Barclays is considering a plan to build out its online retail bank in the U.S. as well as possibly introduce its U.K. payments platform in that country to generate growth.
Mr. Campili joins Barclays after a 12-year career at Deutsche Bank where he was most recently global head of health-care banking and worked on deals such as last year's 4.1-billion euro private-equity buyout of German drug maker Stada Arzneimittel. He is set to start his new role at the end of the summer.
Write to Ben Dummett at firstname.lastname@example.org